469 related articles for article (PubMed ID: 25272281)
1. Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.
Lenton S; Dietze P; Olsen A; Wiggins N; McDonald D; Fowlie C
Drug Alcohol Rev; 2015 Jul; 34(4):404-11. PubMed ID: 25272281
[TBL] [Abstract][Full Text] [Related]
2. Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.
Kerr D; Dietze P; Kelly AM; Jolley D
J Urban Health; 2008 May; 85(3):352-60. PubMed ID: 18347990
[TBL] [Abstract][Full Text] [Related]
3. Implementing take-home naloxone in an urban community pharmacy.
Akers JL; Hansen RN; Oftebro RD
J Am Pharm Assoc (2003); 2017; 57(2S):S161-S167. PubMed ID: 28202384
[TBL] [Abstract][Full Text] [Related]
4. An overview of take-home naloxone programs in Australia.
Dwyer R; Olsen A; Fowlie C; Gough C; van Beek I; Jauncey M; Lintzeris N; Oh G; Dicka J; Fry CL; Hayllar J; Lenton S
Drug Alcohol Rev; 2018 May; 37(4):440-449. PubMed ID: 29744980
[TBL] [Abstract][Full Text] [Related]
5. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
Maxwell S; Bigg D; Stanczykiewicz K; Carlberg-Racich S
J Addict Dis; 2006; 25(3):89-96. PubMed ID: 16956873
[TBL] [Abstract][Full Text] [Related]
6. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose: challenges and opportunities.
Beletsky L; Ruthazer R; Macalino GE; Rich JD; Tan L; Burris S
J Urban Health; 2007 Jan; 84(1):126-36. PubMed ID: 17146712
[TBL] [Abstract][Full Text] [Related]
7. Opioid education and nasal naloxone rescue kits in the emergency department.
Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E
West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910
[TBL] [Abstract][Full Text] [Related]
8. The pharmacist role in the development and implementation of a naloxone prescription program in Alabama.
Wulz JL; Sung H; Dugan BD; Wensel TM; Lander R; Manzella B
J Am Pharm Assoc (2003); 2017; 57(2S):S141-S147. PubMed ID: 28209338
[TBL] [Abstract][Full Text] [Related]
9. From Peers to Lay Bystanders: Findings from a Decade of Naloxone Distribution in Pittsburgh, PA.
Bennett AS; Bell A; Doe-Simkins M; Elliott L; Pouget E; Davis C
J Psychoactive Drugs; 2018; 50(3):240-246. PubMed ID: 29424656
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with naloxone administration in an opioid dependent sample.
Kenney SR; Anderson BJ; Bailey GL; Stein MD
J Subst Abuse Treat; 2018 Jan; 84():17-20. PubMed ID: 29195589
[TBL] [Abstract][Full Text] [Related]
11. Training family members to manage heroin overdose and administer naloxone: randomized trial of effects on knowledge and attitudes.
Williams AV; Marsden J; Strang J
Addiction; 2014 Feb; 109(2):250-9. PubMed ID: 24103087
[TBL] [Abstract][Full Text] [Related]
12. Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.
Winston I; McDonald R; Tas B; Strang J
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370638
[TBL] [Abstract][Full Text] [Related]
13. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation.
McDonald R; Campbell ND; Strang J
Drug Alcohol Depend; 2017 Sep; 178():176-187. PubMed ID: 28654870
[TBL] [Abstract][Full Text] [Related]
14. The extent of and factors associated with self-reported overdose and self-reported receipt of naloxone among people who inject drugs (PWID) in England, Wales and Northern Ireland.
O'Halloran C; Cullen K; Njoroge J; Jessop L; Smith J; Hope V; Ncube F
Int J Drug Policy; 2017 Aug; 46():34-40. PubMed ID: 28586701
[TBL] [Abstract][Full Text] [Related]
15. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths.
Rando J; Broering D; Olson JE; Marco C; Evans SB
Am J Emerg Med; 2015 Sep; 33(9):1201-4. PubMed ID: 26095132
[TBL] [Abstract][Full Text] [Related]
16. Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study.
Marshall C; Perreault M; Archambault L; Milton D
Int J Drug Policy; 2017 Mar; 41():19-28. PubMed ID: 28027483
[TBL] [Abstract][Full Text] [Related]
17. Implementing an overdose education and naloxone distribution program in a health system.
Devries J; Rafie S; Polston G
J Am Pharm Assoc (2003); 2017; 57(2S):S154-S160. PubMed ID: 28233681
[TBL] [Abstract][Full Text] [Related]
18. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study.
Seal KH; Thawley R; Gee L; Bamberger J; Kral AH; Ciccarone D; Downing M; Edlin BR
J Urban Health; 2005 Jun; 82(2):303-11. PubMed ID: 15872192
[TBL] [Abstract][Full Text] [Related]
19. An Innovative Model for Naloxone Use Within an OTP Setting: A Prospective Cohort Study.
Katzman JG; Takeda MY; Bhatt SR; Moya Balasch M; Greenberg N; Yonas H
J Addict Med; 2018; 12(2):113-118. PubMed ID: 29227321
[TBL] [Abstract][Full Text] [Related]
20. Should we conduct a trial of distributing naloxone to heroin users for peer administration to prevent fatal overdose?
Lenton SR; Hargreaves KM
Med J Aust; 2000 Sep; 173(5):260-3. PubMed ID: 11130352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
